Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:871-872 (28 October), doi:10.1136/bmj.39003.629606.BE (published 17 October 2006)
Will the opportunity be missed?
| The first 150 words of the full text of this article appear below. |
This month the European Commission must decide whether to adopt a strategy to deal with the adverse health consequences of alcohol. The strategy has been awaited eagerly by Europe's public health community since it was first mooted five years ago, but it could fall at the last hurdle. It may be the victim of a carefully planned attack by representatives of the alcohol industry, using tactics associated with tobacco manufacturers.
Alcohol related disease accounts for almost 8% of the overall burden of disease in Europe.1 One factor contributing to the current level of consumption is the single European market, testified to by the existence of vast retail outlets around Calais that thousands of British travellers visit each week. Yet the single market has implications that go far beyond this type of cross border trade. Countries such as Sweden and Finland had longstanding stringent controls on alcohol sales that restricted
Martin McKee, professor of European public health
London School of Hygiene and Tropical Medicine, London WC1E 7HT
(martin.mckee@lshtm.ac.uk)